R&D Partner Content 4th Mitochondrial Dysfunction Drug Development Summit Uncover mitochondrial pathogenic mechanisms to show clinical efficacy for regulatory success
R&D Partner Content R&D Procurement & Outsourcing in Biopharma West Summit An event to empower you with the knowledge and tools to excel in procurement and outsourcing
R&D Partner Content 8th Annual Complement-Based Drug Development Summit Achieving Efficacy & Exploring Indication Expansion for Complement Inhibitors
R&D Partner Content 4th annual Rare & Genetic Kidney Disease Drug Development Su... Uncover Disease Pathophysiology, Clarify Response Biomarkers, Leverage Electronic Health Records & Implement Patient-Centric Recruitment Strategies to Accelerate Game-Changing Therapies
R&D Partner Content LEAP HR: Emerging Biopharma Lead The Future in Emerging Biopharma: Revolutionize Your HR Strategy, Develop Top Talent & Empower Your Team to Secure Success Amidst Industry Turbul
R&D Partner Content 15th World ADC San Diego 2024 The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.